trial

Cognitive Rehabilitation in Schizophrenia

NCTId NCT00248794
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 59 (actual)
Sponsored by VA Office of Research and Development
Primary completion 2008-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
59 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2004-06
Primary completion
2008-12
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Cognitive Rehabilitation Therapy (CRT) + Skill Training (SDG)Skills Group (SDG)

Sponsors

VA Office of Research and DevelopmentLead Sponsor

Investigators

1
Gary BrysonPrincipal Investigator

Sites

1 total
West Haven, United States

Facts & assertions

4 sourced
Enrollment
59
Phase
NA
Primary Completion Date
2008-12
Status
COMPLETED
relationships
The graph out of here
drug
Cognitive Rehabilitation Therapy (CRT) + Skill Training (SDG)
drug
Skills Group (SDG)
drug
lead_sponsor
VA Office of Research and Development
company
indication
Cognitive Impairment
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Gary Bryson
person